You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永勝醫療(01612.HK)一季度總收入達1.813億港元 同比增長40.3%
格隆匯 04-15 16:36

格隆匯 4 月 15日丨永勝醫療(01612.HK)宣佈,截至2021年3月31日止三個月,集團的總收入達1.813億港元,較2020年同期增加40.3%。

呼吸產品分部同比增長30.8%,增長反映了用於治療2019冠狀病毒病及其他呼吸系統疾病的呼吸類器械和耗材的需求增加。於該期間,集團與多個合作伙伴加強合作,以擴充呼吸產品分部的產品及市場覆蓋,集團管理層相信,儘管2019冠狀病毒病疫情的發展存在不確定因素,惟該等合作將為集團帶來可持續的長期業務。

成像一次性產品及骨科支護復康器具分部的收入分別錄得61.9%及34.8%的增長,主要是由於推出新產品及產品需求回覆至2019冠狀病毒病之前的水平所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account